| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |